Akanda Corp. Common Shares (AKAN)
AKAN trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC filing XBRL, 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1888014/000121390026066800/0001213900-26-066800-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | AKAN on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | United Kingdom |
| IPO year | 2022 |
| SEC CIK | 0001888014 |
| SEC industry code | Communications Services, NEC |
| Incorporated in | ON |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $258K |
| Net income | -$1.2M |
| Operating income | -$5.0M |
| Net margin | -467.1% |
| Operating margin | -1931.0% |
| Revenue growth | -69.2% |
| Cash | $504K |
| Total assets | $6.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 20.5× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "As discussed in Note 1 to the consolidated financial statements, the Company's significant operating losses and cash outflows raise substantial doubt about its ability to continue as a going concern." | 20-F 2026-06-09 |
| Cash and burn | $504K cash; operating cash flow -$1.7M a quarter. | Report 2025-12-31 |
| Shares outstanding | 1,983,546 (2025-12-31); 2,047,332 a year earlier; 34,637,379 three years earlier. 1y figure adjusted for splits (1-for-70.383 overall); 3y figure adjusted for splits (1-for-5630.631 overall); the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | 5; latest 1-for-4.505 on 2026-04-13 | Source 2026-04-13 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | GreenGrowth CPAs, Los Angeles, California, United States | PCAOB Form AP 2026-06-23 |
| Late filings, 12 months | 1 NT notice | NT 20-F 2026-05-01 |
| Insider trades, 12 months | Bought $41K, sold $10K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | $258K | -$1.2M | -$6.7M | $504K | $1.0M | $258K | 20-F 2026-06-09 |
| FY 2024 2024-12-31 | $837K | -$4.1M | -$4.0M | $3.8M | $353K | $837K | 20-F 2025-04-30 |
| FY 2023 2023-12-31 | $424K | -$32.3M | -$1.5M | $94K | $3.9M | $424K | 20-F 2025-04-30 |
| FY 2022 2022-12-31 | $2.6M | -$11.7M | -$11.5M | $256K | $937K | $2.6M | 20-F 2024-05-01 |
| FY 2021 2021-12-31 | $41K | -$8.1M | -$6.6M | $3.5M | $6.7M | $41K | 20-F 2023-05-02 |
| FY 2020 2020-12-31 | $2K | -$2.3M | Not filed | $14K | $2.3M | $2K | 20-F 2023-05-02 |
| FY 2019 2019-12-31 | Not filed | -$1.4M | Not filed | $820K | No debt tags | Needs four quarters | 20-F 2023-05-02 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document AMENDMENT NO. 2 TO FORM F-1 | F-1/A | 2026-11-06 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-06-09 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-09-30 |
Source: SEC EDGAR submissions feed, 201 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +61.9% |
| 1 month | -1.4% |
| 3 months | -72.9% |
| Year to date | -86.8% |
| 1 year | -95.3% |
| From 52-week high | -97.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NAII | Natural Alternatives International Inc. | $0.9700 | +0.35% | $6.1M |
| MTEX | Mannatech Incorporated | $3.76 | -40.32% | $7.3M |
| BON | Bon Natural Life Limited | $1.09 | -0.91% | $8.9M |
| IMCC | IM Cannabis Corp. Common Shares | $0.4950 | -12.76% | $913K |
| BTMD | Biote Corp. | $0.9603 | -9.83% | $34.5M |
| FTLF | FitLife Brands Inc. | $6.83 | -19.46% | $64.1M |
| ISPR | Ispire Technology Inc. | $1.52 | -10.06% | $87.8M |
| XXII | 22nd Century Group Inc. | $0.4932 | -35.96% | $272K |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier